129 related articles for article (PubMed ID: 26863454)
1. Metabolic vulnerabilities of MYC-induced cancer.
Gouw AM; Toal GG; Felsher DW
Oncotarget; 2016 May; 7(21):29879-80. PubMed ID: 26863454
[No Abstract] [Full Text] [Related]
2. MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism.
Shroff EH; Eberlin LS; Dang VM; Gouw AM; Gabay M; Adam SJ; Bellovin DI; Tran PT; Philbrick WM; Garcia-Ocana A; Casey SC; Li Y; Dang CV; Zare RN; Felsher DW
Proc Natl Acad Sci U S A; 2015 May; 112(21):6539-44. PubMed ID: 25964345
[TBL] [Abstract][Full Text] [Related]
3. Oncogenes and growth factors in renal cell carcinoma.
Peter S
Urol Int; 1991; 47(4):199-202. PubMed ID: 1781103
[TBL] [Abstract][Full Text] [Related]
4. [Overexpression of c-myc, c-fos and Harvey ras oncogenes in renal cancers--analysis at the messenger RNA levels].
Kunimi K; Uchibayashi T; Hisazumi H
Nihon Hinyokika Gakkai Zasshi; 1991 Dec; 82(12):1924-9. PubMed ID: 1779495
[TBL] [Abstract][Full Text] [Related]
5. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma.
Furge KA; Chen J; Koeman J; Swiatek P; Dykema K; Lucin K; Kahnoski R; Yang XJ; Teh BT
Cancer Res; 2007 Apr; 67(7):3171-6. PubMed ID: 17409424
[TBL] [Abstract][Full Text] [Related]
6. MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma.
Bailey ST; Smith AM; Kardos J; Wobker SE; Wilson HL; Krishnan B; Saito R; Lee HJ; Zhang J; Eaton SC; Williams LA; Manocha U; Peters DJ; Pan X; Carroll TJ; Felsher DW; Walter V; Zhang Q; Parker JS; Yeh JJ; Moffitt RA; Leung JY; Kim WY
Nat Commun; 2017 Jun; 8():15770. PubMed ID: 28593993
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of renal cell carcinoma.
Vignoli GC; Martorana G
Arch Ital Urol Androl; 1997 Sep; 69(4):265-9. PubMed ID: 9396188
[TBL] [Abstract][Full Text] [Related]
8. L-MYC allelotype in renal cell carcinoma.
Presti JC; Hinckley J; Reuter VE
Cancer Genet Cytogenet; 1996 May; 88(1):66-8. PubMed ID: 8630982
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal defects in renal cell carcinoma.
Anderson GA; Lawson RK
Urology; 1992 May; 39(5):473-7. PubMed ID: 1580044
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic, molecular and phenotypic characterization of the newly established renal carcinoma cell line KJ29. Evidence of translocations for chromosomes 1 and 3.
Barletta C; Bartolazzi A; Cimino Reale G; Gambari R; Nastruzzi C; Barbieri R; Del Senno L; Castagnoli A; Natali PG
Anticancer Res; 1995; 15(5B):2129-36. PubMed ID: 8572614
[TBL] [Abstract][Full Text] [Related]
11. Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma.
Kozma L; Kiss I; Nagy A; Szakáll S; Ember I
Cancer Lett; 1997 Jan; 111(1-2):127-31. PubMed ID: 9022137
[TBL] [Abstract][Full Text] [Related]
12. A 1.5-megabase restriction map surrounding MYC does not include the translocation breakpoint in familial renal cell carcinoma.
Gemmill RM; Coyle-Morris J; Ware-Uribe L; Pearson N; Hecht F; Brown RS; Li FP; Drabkin HA
Genomics; 1989 Jan; 4(1):28-35. PubMed ID: 2914707
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and amplification of c-myc in the Syrian hamster kidney during estrogen carcinogenesis: a probable critical role in neoplastic transformation.
Li JJ; Hou X; Banerjee SK; Liao DZ; Maggouta F; Norris JS; Li SA
Cancer Res; 1999 May; 59(10):2340-6. PubMed ID: 10344741
[TBL] [Abstract][Full Text] [Related]
14. The allelic loss of chromosome 3p25 with c-myc gain is related to the development of clear-cell renal cell carcinoma.
Yamaguchi S; Yoshihiro S; Matsuyama H; Nagao K; Fukunaga K; Matsumoto H; Matsuda K; Oba K; Naito K
Clin Genet; 2003 Mar; 63(3):184-91. PubMed ID: 12694227
[TBL] [Abstract][Full Text] [Related]
15. Translocation of c-myc in the hereditary renal cell carcinoma associated with a t(3;8)(p14.2;q24.13) chromosomal translocation.
Drabkin HA; Bradley C; Hart I; Bleskan J; Li FP; Patterson D
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):6980-4. PubMed ID: 2995998
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
[TBL] [Abstract][Full Text] [Related]
17. Expression of proto-oncogenes in xenografts of human renal cell carcinomas.
Karthaus HF; Bussemakers MJ; Schalken JA; Kurth KH; Feitz WF; Debruyne FM; Bloemers HP; Van de Ven WJ
Urol Res; 1987; 15(6):349-53. PubMed ID: 3324444
[TBL] [Abstract][Full Text] [Related]
18. Kidney cancer: Mice with Flcn knockout in proximal tubules-an in vivo model for multiple RCC subtypes.
Thoma C
Nat Rev Urol; 2015 Aug; 12(8):420. PubMed ID: 26150235
[No Abstract] [Full Text] [Related]
19. [Heredity in renal and prostatic neoplasia].
Prayer Galetti T; D'Arrigo L; De Zorzi L; Patarnello T
Arch Ital Urol Androl; 1997 Sep; 69(4):241-6. PubMed ID: 9417296
[TBL] [Abstract][Full Text] [Related]
20. [Renal cell cancer: oncogenes and tumor suppressor genes].
Dietrich PY; Droz JP
Rev Prat; 1992 May; 42(10):1236-40. PubMed ID: 1609216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
